Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1.58 Billion | USD 4.22 Billion | 10.3% | 2024 |
The global anti-snoring treatment market size was worth around USD 1.58 Billion in 2024 and is predicted to grow to around USD 4.22 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 10.3% between 2025 and 2034. The report analyzes the global anti-snoring treatment market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the anti-snoring treatment industry.
Snoring is a common disorder caused due to result of repetitive narrowing and collapsing of the upper airway. Snoring not only disrupts the sleeping pattern but also weakens the sleep quality of a person. Habitual snoring can be a sign of serious health problems and obstructive sleep apnea like light sleeping, interruptions in breathing, frequent waking from sleep, the strain on the heart, and poor night sleep. Hence, snoring requires treatment and is referred to as anti-snoring treatment. There are non-surgical treatments as well as surgical treatments for snoring. Some of the recommended anti-snoring treatments include weight loss and positioning therapy. For the record, mandibular protrusion splints can reduce snoring in particular cases. Moreover, if breathing through the nose is obstructed, either rhinoplasty treatment or minimally invasive surgery is recommended.
Irregular eating habits and intake of alcoholic beverages have promoted the global market demand
Changing lifestyles and unhealthy dietary habits like consumption of alcohol, tobacco, and smoking are some of the factors triggering the growth of the anti-snoring treatment market globally. Growing cases of sleeping disorders & rise in obesity among individuals will pave the way for the growth of the market across the globe. A surge in the aging populace prone to snoring disorder has led to the massive demand for snore-controlling equipment, thereby proliferating the global market trends. Technological breakthroughs in anti-snoring equipment & anti-snoring surgeries will exalt the growth of the global market. The increase in the incidences of obstructive sleep apnea has culminated in a noteworthy expansion of the market space across the globe. The introduction of new anti-snoring treatments will promote global market trends. For instance, in February 2023, Healthpoint, a Mubadala Health partner of a U.S.-based health unit, launched a new diagnostic method in the UAE. The move is aimed at helping treat people having obstructive sleep apnea that causes loud snoring and stops breathing in patients for a short period along with depriving the body & brain from getting oxygen.
High prices of anti-snoring treatment equipment to impede the global industry expansion over 2023-2030
The rise in the costs of anti-snoring treatment devices and the lack of availability of favorable compensation will retard the elevation of the anti-snoring treatment industry across the globe. Moreover, anti-snoring treatments are very expensive and hence it is not affordable for the population in emerging countries as well as those belonging to the middle-income group. This aspect can severely affect the expansion of the industry globally.
An increase in popularity of anti-snoring applications will open new vistas of growth for the global market
A surge in the use of anti-snoring apps, dental equipment, mandibular advancing equipment, behavioral treatment, and tongue stabilizing equipment has opened new avenues of growth for the global anti-snoring treatment market. Moreover, inactive lifestyles, unhealthy eating habits, and a rise in alcohol intake along with sleep disorders will generate new facets of growth for the market globally.
The allergic reaction occurring due to anti-snoring treating equipment can prove to be a big challenge for the global industry surge
Some of the users can find the anti-snoring treating equipment uncomfortable and this can be one of the challenging aspects for the global anti-snoring treatment industry expansion. In addition to this, the equipment can cause pain in the face & jaw initially for a few of the patients. Moreover, some of the subjects can be allergic to anti-snoring treatment devices and this can further hinder the demand & sales of the devices.
The global anti-snoring treatment market is sectored into device type, end-user, and region.
In device type terms, the global anti-snoring treatment market is segregated into mandibular advancement devices (MAD), tongue stabilizing devices (TSD), continuous positive airway pressure (CPAP) devices, and nasal devices segments. In addition to this, the continuous positive airway pressure (CPAP) devices segment, which garnered nearly 60% of the global market share in 2022, is projected to record the fastest CAGR in the upcoming years. The growth of the segment in the ensuing years can be due to a rise in the demand for continuous positive airway pressure (CPAP) devices in treating snoring as well as obstructive sleep apnea disorders.
Based on end-user, the global anti-snoring treatment industry is bifurcated into hospitals, specialty clinics, ambulatory surgical centers, and others segments. In addition to this, the specialty clinics segment, which contributed remarkably towards the global industry share in 2024, is set to establish dominance in the global industry in the years to come. The segmental expansion over the assessment timeline can be due to large-scale demand for anti-snoring treatment devices in specialty clinics in both emerging economies as well as developed countries.
Report Attributes | Report Details |
---|---|
Report Name | Anti-Snoring Treatment Market |
Market Size in 2024 | USD 1.58 Billion |
Market Forecast in 2034 | USD 4.22 Billion |
Growth Rate | CAGR of 10.3% |
Number of Pages | 218 |
Key Companies Covered | Aegean Medical Inc., Natus Medical Inc., Inspire Medical Systems Inc., Tomed Dr. Toussaint Gmbh, ResMed, AccuMED Corporation, GlaxoSmithKline, Apnea Sciences Corporation, Theravent Inc., Braebon Medical Corporation, Sonomed Limited, Pure Sleep Company, GE Healthcare, Meditas, ImThera Medical Inc., Koninklijke Philips N.V., Airway Management Inc., Zephyr Sleep Technologies, Medtronic plc, Sleeping Well LLC, Fisher & Paykel Healthcare, and others. |
Segments Covered | By Device Type, By End-User, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA) |
Base Year | 2024 |
Historical Year | 2020 to 2023 |
Forecast Year | 2025 - 2034 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America is likely to establish a numero uno position in the global market over 2025-2034
North America, which accounted for half of the global anti-snoring treatment market share in 2022, will be the leading region during the forecast period. Moreover, the launching of new modes of treatment for treating sleep disorders in countries such as Canada and the U.S. will proliferate the regional market size. Apart from this, the presence of key anti-snoring treating device manufacturers in these countries will extend the scope of the regional market in the forthcoming years. Launching of new products will contribute notably towards the regional market proceeds in the upcoming years. In the first quarter of 2021, the U.S. Food and Drug Administration approved the commercial launch of eXciteOSA, anti-snoring equipment launched by Rotech Healthcare, a key U.S.-based firm providing sleep apnea therapy to patients.
The Asia-Pacific anti-snoring treatment industry is set to register the highest CAGR over the forecast timeline owing to the presence of a large population pool of untreated people facing snoring issues. In addition to this, the rise in awareness about snoring as an illness has created new avenues of growth for the market in the Asia-Pacific zone. Furthermore, new product launches will contribute lucratively towards the regional industry earnings in the upcoming years. In May 2022, Illusion Designers, a key Indian player in the dental sector, launched an anti-snoring device. Reportedly, the new device is easy to wear, lightweight, relieves obstructive sleep apnea symptoms, minimizes fatigue, and enhances the quality of life in patients.
The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the anti-snoring treatment market on a global and regional basis.
The global anti-snoring treatment market is dominated by players like:
The global anti-snoring treatment market is segmented as follows;
By Device Type
By End-User
By Region
FrequentlyAsked Questions
Snoring is a common disorder caused due to result of repetitive narrowing and collapsing of the upper airway. Snoring not only disrupts the sleeping pattern but also weakens the sleep quality of a person. There are non-surgical treatments as well as surgical treatments for snoring. Some of the recommended anti-snoring treatments include weight loss and positioning therapy.
The global anti-snoring treatment market is expected to grow due to rising prevalence of sleep apnea, increasing health awareness, technological advancements in oral devices, and growing demand for non-invasive solutions.
According to a study, the global anti-snoring treatment market size was worth around USD 1.58 Billion in 2024 and is expected to reach USD 4.22 Billion by 2034.
The global anti-snoring treatment market is expected to grow at a CAGR of 10.3% during the forecast period.
The Asia-Pacific anti-snoring treatment t industry is set to register the highest CAGR over the forecasting timeline owing to the presence of a large population pool of untreated people facing snoring issues. In addition to this, the rise in awareness about snoring as an illness has created new avenues of growth for the market in the Asia-Pacific zone.
Leading players in the global anti-snoring treatment market include Aegean Medical Inc., Natus Medical Inc., Inspire Medical Systems Inc., Tomed Dr. Toussaint Gmbh, ResMed, AccuMED Corporation, GlaxoSmithKline, Apnea Sciences Corporation, Theravent Inc., Braebon Medical Corporation, Sonomed Limited, Pure Sleep Company, GE Healthcare, Meditas, ImThera Medical Inc., Koninklijke Philips N.V., Airway Management Inc., Zephyr Sleep Technologies, Medtronic plc, Sleeping Well LLC, Fisher & Paykel Healthcare, among others.
The report explores crucial aspects of the anti-snoring treatment market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed